Sanara MedTech Inc.
For the period ended Dec 31, 2024. Filed Mar 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 25, 2025
SMTI$32.10+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders’ Equity
| Common Stock $0.001 par value · Additional Paid-In · Accumulated · Noncontrolling · Total Shareholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Interest | Equity | |
| Balance at December 31, 2022 | 8,299,957 | $8,300 | $65,213,987 | $(23,394,757) | $(107,555) | $41,719,975 |
| Share-based compensation | 100,829 | 100 | 3,442,622 | - | - | 3,442,722 |
| Net settlement and retirement of equity-based awards | 34,501 | 35 | 203,031 | (338,860) | - | (135,794) |
| Issuance of common stock for acquisitions | 73,809 | 74 | 3,089,571 | - | - | 3,089,645 |
| Issuance of common stock in equity offering | 26,143 | 26 | 911,345 | - | - | 911,371 |
| Net loss | - | - | - | (4,303,197) | (136,705) | (4,439,902) |
| Balance at December 31, 2023 | 8,535,239 | $8,535 | $72,860,556 | $(28,036,814) | $(244,260) | $44,588,017 |
| Share-based compensation | 164,451 | 165 | 4,435,883 | - | - | 4,436,048 |
| Net settlement and retirement of equity-based awards | 54,083 | 54 | (42,228) | (83,031) | - | (125,205) |
| Issuance of common stock in equity offering | - | - | (75,000) | - | - | (75,000) |
| Net loss | - | - | - | (9,664,547) | (247,351) | (9,911,898) |
| Balance at December 31, 2024 | 8,753,773 | $8,754 | $77,179,211 | $(37,784,392) | $(491,611) | $38,911,962 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.